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1. Introduction 
Porcine reproductive and respiratory syndrome (PRRS) is a highly contagious viral disease 
that was first recognized almost simultaneously in Western Europe (Wensvoort et al., 1991) 
and North America in the late 1980s (Keffaber, 1989). The causative agent is PRRS virus 
(PRRSV), a small single-stranded positive sense RNA virus, classified in the order Nidovirales, 
family Arteriviridae and genus Arterivirus. Since its appearance, PRRS has devastated the 
worldwide swine industry with tremendous economic losses (Neumann et al., 2005). PRRSV 
causes reproductive failure in breeding stock (e.g. premature farrowings, late term abortions, 
poor farrowing rate, mummified fetuses and stillborn piglets), as well as respiratory disease, 
elevated mortality and reduction of growth performance in piglets and growing / finishing 
pigs (Cho & Dee, 2006). Generally, after an acute outbreak of a PRRSV infection, herds may 
undergo a chronic loss of production in growing / finishing pigs and an endemic infection of 
breeding stock characterized by several outbreaks throughout the year (Stevenson et al., 1993). 
The severity of PRRS may result from a number of factors such as differences in virulence 
among the PRRSV isolates, probable recombination between the different isolates within the 
same farm, immune status, host susceptibility and concurrent infections (other viruses and 
bacteria) and hygiene monitoring programme (Goldberg et al., 2000). PRRSV infected pigs 
are more susceptible to some bacterial (e.g. Mycoplasma hyopneumoniae, Actinobacillus 
pleuropneumoniae, Bordatella bronchiseptica, Pasteurella multocida, Haemophilus parasuis, 
Streptococcus suis) and viral diseases (e.g. swine influenza virus, Aujezky's disease virus, 
porcine respiratory coronavirus, porcine circovirus 2 - PCV2) (Brockmeier et al., 2002). One 
of the main pathogens involved in the porcine respiratory disease complex (PRDC) is 
PRRSV, as it has an additive or synergistic effect with the above other bacteria or viruses, 
that leads to a more severe and chronic respiratory disease in growing / finishing pigs 
(Thacker, 2006).  
Before trying to control diseases at the farm level, it is very important to get information 
about what we really have to control. For instance, it is important to understand the 
pathogenesis, epidemiology and clinical forms of diseases. Therefore, the more scientific 
knowledge is known about PRRS, the better are the chances that this disease will be kept 
under control at relatively low losses. Table 1 shows some basic information of PRRSV 
infection at farm level (Cho & Dee 2006; Zimmerman et al., 2006). 
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Infection source 
 Direct contact, nasal secretions, saliva, urine, feces, milk, semen, 
blood, aerosol, transplacental, fomites (e.g. boots, coveralls), 
equipment, insects, vehicles, human 
Incubation time  3 days and over 
Shedding period  99 days 
Survival in the 
environment 
 Less than 24 hours at 25oC on solid material 
 9 to 11 days in water at 25oC 
 8 days in lagoon water at 4oC 
 Stable at pH 6.5–7.5, but infectivity is rapidly lost at below 6 > pH  < 7.5 
 Survival >4 months at -70 to -20°C / its viability decreases with 
increasing temperature  
 90% of PRRSV infectivity is lost within 1 week at 4°C, but low titers 
of infectious virus can still be detected for at least 30 day  
 In solution, PRRSV infectivity persists for 1–6 days at 20–21°C, 3–24 
hours at 37°C, and 6–20 minutes at 56°C 
 Shedding of PRRSV in saliva, urine, and feces are high risk factors 
for the environmental contamination  
Other properties 
 High biological, antigenic, genetic and pathogenic heterogeneity 
exists among PRRSV strains / genetically diverse PRRSV strains 
may coexist in the same farm 
 Partial and variable cross protection between isolates 
 Frequent genetic changes or recombination  
 Fetuses are most susceptible to active infection after 60 days of 
conception  
 Pigs may become carriers until at least 150 days of age (PRRSV 
persistence) 
 PRRSV is associated with outbreaks of other pathogens 
 Lack of complete heterologous protection by commercial vaccines 
Table 1. Main information about PRRSV infection for a herd health management programme 
The above information should not be used as definitive, as many factors may interact with 
field situations that can result in potential timeline changes. Veterinary medicine, just as 
human medicine, is not a static science. So, it is possible that the scientific data for PRRS 
could change year by year. The data of Table 1 are very basic and representative of the 
scientific literature regarding PRRSV infection in order to take decisions on what herd 
health management practices should be applied in a farm. For this reason, the above data 
should be interpreted, since the goal at farm level is the herd and not individual animals.  
2. Principles of a porcine herd health management programme in PRRSV 
infected farms 
2.1 Biosecurity measures 
Biosecurity measures are always a fundamental part of a porcine herd health management 
programme. Generally, the risk of a herd becoming PRRSV-positive increases with: a) 
density of PRRSV-positive neighboring herds, within 500 meters; b) increasing herd size; c) 
high number of animal introductions; d) purchase of semen for artificial insemination; e) 
absence of quarantine for replacement boars and gilts (Weigel et al., 2000). The aim of 
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porcine herd health management programmes for the prevention and control of PRRSV 
infection is either to stop the introduction of PRRSV into negative herds or limit the 
introduction of new strains into already PRRSV-infected herds. However, the control of 
PRRS in a herd, continuously exposed to exogenous infection, is a loss of time and money. 
Biosecurity measures should be reviewed with attention to both internal and external 
biosecurity. External biosecurity deals with the risk of introduction of new PRRSV strains or 
other co-infections from outside the farm. Internal biosecurity deals with the spread of 
PRRSV within a farm after the exogenous introduction of the virus. Table 2 shows the basic 
elements of a biosecurity programme for a commercial farrow-to-finish farm or a sow unit. 
Gilts source  PRRSV negative or at least non-shedding  
 Site of gilt production should be away from any other pig facilities 
Semen source  PRRSV negative boar stud 
 Unit under air filtration or far from any other pig facilities 
Quarantine  For a minimum of 30 days before the introduction into the herd 
 Separate building than the main unit 
AIAO  Strictly applied in farrowing rooms, nursery and finisher 
 Washing/disinfecting/drying between batches 
 Consider batch farrowing to facilitate AIAO 
Environment/Fee
d, water, air 
 Mechanical air filtration 
 Water sanitation 
 Feed free of mycotoxins / balanced energy and amino acids 
Equipment / 
instruments 
 One set of processing equipment should be disinfected while the other is 
in use 
 Boots, hands and coveralls should be kept clean 
 Disposable gloves can be used between litters 
 Separate equipment (shovels, brooms, scrapers) should be used for the 
manure passage and the feed alley at all times in order to reduce the risk 
of PRRSV spread  
 Needles: Sows and Boars: discard after one injection / Piglets: discard after 
each litter or pen 
 Equipment / instruments for castration, tooth-clipping or tail-docking: 
Washing and heating (propane burner) between litters; Disinfection after using 
Transport  Transport of  pigs in cleaned vehicles (washing, disinfection, drying) 
Hygiene  Disinfectants 
 Washing of boots at the end of the day with a brush and disinfect in a bath 
of disinfectant (new disinfectant solution should be used every day) 
 Scrape sow’s manure each day in farrowing room with a shovel (1 
shovel per room) 
 Carcass disposal: compost or incineration 
Personnel / 
Visitors 
 Minimize the numbers of visitors 
 Wash hands  
 Fomites belonging to the farm 
 Forbid to enter equipment, tools or materials in the farm that have been 
in contact with pigs or pig manure of other farms 
Table 2. Basic elements of a biosecurity programme for a commercial farrow-to-finish farm 
or a sow unit 
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Direct routes of PRRSV transmission within and between pig populations include infected 
animals and contaminated semen. For this reason, all replacement boars and gilts should 
originate from PRRSV negative farms and be properly isolated in quarantine facilities for 
a minimum of 30 days, including serological tests and PRRSV vaccinations prior to their 
introduction into the herd. Ideally, isolation facilities should be located on another farm 
site and visited at the end of the working day. Moreover, semen for artificial insemination 
should come from PRRSV-negative boar studs. Indirect transmission involves 
transmission by fomites (boots and coveralls), contaminated equipment (e.g. needles), 
farm personnel and visitors, transport vehicles (contaminated trailers, coolers, containers), 
substances (e.g., water, food), insects (e.g. houseflies and mosquitoes), or aerosols (Dee et 
al., 2002; Cho & Dee, 2006; Desrosiers, 2011). In general, biosecurity efforts should focus 
on all inputs and outputs of the farms, such as pigs, supplies and materials, feed, water, 
personnel, removal of manure, and reclaims. In addition, the entry of pests such as 
rodents, insects, and birds from all buildings should be avoided (Zimmerman et al., 2006). 
Finally, All-in/All-out (AIAO) pig flow is effective in controlling a variety of respiratory 
pathogens in weaned pigs. AIAO consists of dividing buildings into individual rooms, 
allowing thorough cleaning and disinfection of facilities between groups of pigs. This 
method is very effective in reducing the horizontal spread of PRRSV from older, infected 
pigs to those recently placed in the finishing stage. Although, AIAO does not directly 
control the transmission of PRRSV, it reduces the impact of secondary bacterial co- 
infections. 
The disinfection is crucial for a biosecurity programme in a PRRSV-infected farm. The 
survival of PRRSV outside a living host is affected by factors that include the substrate, 
pH, temperature, relative humidity, and exposure to ultraviolet light. PRRSV is 
inactivated by lipid solvents, such as chloroform and ether. In addition, at “room 
temperature” the virus can be inactivated completely with the use of chlorine (0.03%) in 
10 minutes, iodine (0.0075%) in 1 minute, and a quaternary ammonium compound 
(0.0063%) in 1 minute (Shirai et al., 2000). PRRSV is also relatively labile in the 
environment and particularly susceptible to heating and drying (Pirtle & Beran, 1996). 
Leaving a room to completely dry with or without supplemental heating is one of the 
most effective ways of killing viruses and bacteria. PRRSV can remain infectious for an 
extended time under specific conditions of temperature, moisture, and pH. It is stable at 
pH 6.5–7.5, but infectivity is rapidly lost at pH below 6 and above 7.5 (Bloemraad et al., 
1994). At temperatures ranging from -70 to -20°C, PRRSV can survive more than 4 
months, but when temperature increases, its survivability decreases. Approximately 90% 
of PRRSV infectivity is lost within 1 week at 4°C, but low titers of infectious virus can still 
be detected for at least 30 days. In solution, the virus infectivity persists for 1–6 days at 
20–21°C, 3–24 hours at 37°C, and 6–20 minutes at 56°C (Zimmerman et al., 2006). At 25–
27°C, infectious PRRSV is not detected on plastic, stainless steel, rubber, alfalfa, wood 
shavings, straw, corn, swine starter feed, or denim cloth (Pirtle & Beran, 1996). Cleaned 
and disinfected pens should be left to dry for a minimum of 24 hours before pigs are 
placed, while barns should be allowed to dry for a minimum of 7 - 14 days between 
batches. Since PRRSV persists in cold and wet conditions, all equipment and material 
used at the farm or for transport of pigs must be cleaned and dried (Dee et al., 2002). 
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Herd health management has a significant impact on disease expression, as some 
management parameters like environmental conditions, water and feed quality may 
compromise affect the animal resistance to diseases. In addition, the above management 
parameters if are not in compliance with the rules of animal welfare can also increase the 
stress and favor virus / bacteria transmission in pigs or have a negative impact on 
immunity against several diseases.  
Water: PRRSV survives in water up to 11 days, but drying quickly inactivates it 
(Zimmerman et al., 2006). It is important to use chlorine or hydrogen peroxide for the water 
sanitation, because water sources and delivery systems may be contaminated with 
pathogens. However, the use of chlorine should be monitored by testing the levels of free 
chlorine. Well capacity, water flow rates, pressure, drinker number, type and placement are 
very important for the optimal water intake. Finally, factors such as mineral content, 
hardness, total dissolved solids, and pH should also be considered.  
Feed: it is unlikely that PRRSV can be transmitted through contaminated feed, but feed 
suppliers present a risk acting as a vector from infected farms to other farms. However, 
energy and amino acids must be balanced in diet, in order to provide the required energy 
for the enhancement of the immune system and the basic building blocks of antibodies. 
Minerals and vitamins are also required in sufficient quantities for the optimal function of 
immune system. According to the rules of animal welfare, feeders must be managed 
appropriately, so that the feeder provides adequate access for each pig. Moreover, the feed 
needs to be free of mould and mildew, because mycotoxins can cause immune suppression, 
resulting in increased incidences of clinical signs of PRRS, such as pneumonia.  
Environment: It plays also a main role, as PRRSV shedding in saliva, urine, and feces is a 
high risk factor for the environmental contamination, creating the potential for transmission 
via fomites (e.g. boots, coveralls), personnel and vehicles. Air exchange rates have an impact 
on control of PRRS. The filtering of air entering pig housing has been proposed as a means 
to reduce the risk of airborne transmission of PRRSV from infected herds to at-risk 
populations (Pitkin et al., 2009). Therefore, air filtration is an effective means to reduce the 
risk of external PRRSV introduction to large breeding herds located in areas with high pig 
population density (Dee et al., 2010). Moreover, increased relative humidity may increase 
the survival time of respiratory pathogens in the room environment and increased 
ventilation rates may increase air speed, causing chilling. Chilling, due to the wide daily and 
rapid small temperature fluctuations, contributes significantly to the increased prevalence of 
disease by increasing stress levels in affected pigs. For this reason, ventilation and 
temperature controllers should be adjusted so as to ensure that they are set to control 
temperature fluctuation and daily variability. The use of simple environmental testing 
equipment, such as humidity monitors, data loggers, air speed and gas testers are very 
important. Moreover, PRRSV can be inactivated through the process of composting or 
incinerating carcasses, so only these methods should be applied. Finally, PRRSV can survive 
in lagoon effluent for up to 3 days at 20 oC and for 7 days at 4 oC. Contact with 
PRRSV-positive effluent can be a source of infection to naïve pigs. Therefore, producers that 
utilize recycled lagoon water in their waste management protocols may be at higher risk for 
external PRRSV introduction than those who use deep pits. 
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2.3 Control strategies 
PRRSV tends to circulate within a herd indefinitely after the initial infection of a herd. For 
example, PRRSV was isolated from nursery pigs up to 3.5 years after the initial PRRS 
outbreak (Larochelle et al., 2003). Several parameters related to the herd (size, management 
and type), or the vaccine (type, management) may determine whether PRRS can be 
successfully controlled in a farm. Unfortunately, the ability of the virus to persist in herds 
and its wide biologic, antigenic and genetic variability may further complicate control plans 
(Zimmerman et al., 2006). In endemically PRRSV infected herds, the virus circulates, 
because, in any given time, animals are in different stages of infection and immunity. 
Control and prevention of the virus should be based on: a) minimizing PRRSV circulation at 
farm level, b) limiting the effects of the virus circulation and secondary bacterial co-
infections and c) maximizing and stabilizing the herd immunity (Dee, 2003).  
2.3.1 Vaccination programmes 
Vaccinations against PRRSV with both modified (or attenuated) live vaccines (MLV) and 
inactivated (or killed) vaccines have frequently been reported by many studies. The absence 
of complete protection has frequently been attributed to antigenic differences and the 
limited cross-reactivity between strains of commercial vaccines and challenge strains. Such 
variability is largely attributed to genetical and antigenical heterogeneity between isolates 
mainly among European and American isolates, but also within the same area or the same 
farm. The high heterogeneity among PRRSV strains is likely to be the main obstacle to 
effective control of PRRSV infection using current commercial vaccines (MLV and 
inactivated), since the immunity induced by one strain may be only partial against a 
different strain, even within the same genotype (Mateu & Diaz, 2008; Kimman et al., 2009). 
However, vaccine efficacy may be associated with an efficient cell-mediated immunity and 
it is not only related with its immunological properties, but also with the characteristics of 
the challenging strain to trigger an immune response (Martelli et al., 2009). Therefore, the 
ability of each strain to induce a strong cell-mediated immune response is more important 
than the genetic similarity between the vaccine strain and the field strains for inducing 
clinical protection (Mateu & Diaz, 2008). The complexity of the immune response to PRRSV 
and the ability of the virus to escape or modulate the host’s immune system make difficult 
the development of  an effective vaccine for control and eradication of PRRS. 
MLV vaccines have been widely used in breeding stock and young piglets. The results of 
many studies have shown beneficial effects on PRRS clinical disease occurrence and 
severity, the duration of viremia and virus shedding (Scortti et al., 2006; Martelli et al., 2007; 
Kimman et al., 2009), as well as improvement of health status and performance of 
gilts/sows and their litters (Alexopoulos et al., 2005). However, the use of MLV vaccines is 
questionable. Virus-neutralizing (VN) antibodies against PRRSV protect against viremia, 
virus replication in lungs, transplacental spreading of the virus and reproductive failure 
(Labarque et al., 2003, 2004; Lopez & Osorio, 2007). MLV vaccination induce VN antibodies 
and protect against viremia, virus replication in lungs and virus induced respiratory and 
reproductive disorders (Labarque et al., 2003; Scortti et al., 2007; Zuckermannet al., 2007). 
The protective immune response induced by current commercial MLV vaccines is 
influenced by genetic diversity, as these vaccines do not always sufficiently protect (or only 
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partially) against re-infection and transplacental infections caused by heterologous strains 
(Scortti et al., 2006; Prieto et al., 2008; Kimman et al., 2009). However, Martelli et al. (2009) 
reported that vaccination of piglets at 5 weeks of age with a commercial MLV vaccine 
induced a partial clinical protection, associated with an efficient cell-mediated immune 
response, when the above vaccinated pigs were exposed to a heterologous field strain. 
Moreover, there are major concerns about the safety of current vaccination programmes 
with MLV vaccines. Experimental and field studies reported that MLV strains can cause 
viremia, revert to virulence and spread transplacentally and horizontally not only within the 
vaccinated herds (transmission and detection in non-vaccinated pigs), but also to 
neighbouring non-vaccinated herds (Bøtner et al., 1997; grosse Beilage et al., 2009; Kimman 
et al., 2009). It is possible that farmers using an MLV vaccine for the first time may 
experience a decrease in the herd productivity. MLV vaccinations in sows reported to cause 
acute PRRS-like clinical signs, characterized by increased late term abortions, increased 
numbers of stillborns and mummified piglets, as well as reduced numbers of live born and 
weaned piglets (Bøtner et al., 1997; Dewey et al., 1999). An additional problem is that the 
MLV vaccination has been shown to decrease the efficacy of Mycoplasma hyopneumoniae 
vaccines (Thacker et al., 2000; Le Roitha et al., 2011). 
Based on the Greek experience, in farms with history of endemic PRRSV infection, the MLV 
vaccination of breeding stock (gilts once at the age of 180 days and sows 10 days post-
partum) can have beneficial effects on their health and performance. Alexopoulos et al. 
(2005) reported  reduction of premature farrowing rate, return-to-oestrus rate, number of 
dead and mummified born piglets as well as the increase of farrowing rate, the number of 
piglets born alive and weaning pigs per litter. Furthermore, in farms affected by both 
PRRSV and PCV2, the MPV vaccinations in piglets (at roughly 5 weeks old) can lead to a 
reduction of morbidity and mortality of growing pigs, as well as an improvement of the 
growth performance in vaccinated pigs (Alexopoulos et al., 2005; Kritas et al., 2007). 
However, recent evidences based on personal experience and field observations in endemic 
PRRSV-infected farms suffering by significant reproductive failure, indicate that the MLV 
vaccination of breeding stock can improve; a) the reproductive performance, b) the viraemic 
status of piglets, c) the morbidity and mortality of piglets, d) the growth performance of 
piglets. The vaccination protocol depends on the average breeding herd size and the current 
clinical expression of PRRS. In cases of; a) large scale farms with a capacity of over 700 sows 
under production, b) farms suffering from acute outbreaks of PRRS and c) endemic PRRSV-
infected farms with 4-5 outbreaks every year, the preferable vaccination schedule includes a 
vaccination at 60th day of gestation and booster at 6th day of lactation. Vaccination at 2-4 
weeks before mating and revaccination before each consecutive gestation is proposed for; a) 
farms with a capacity of over 100-200 sows under production and b) endemic PRRSV-
infected farms with 4-5 outbreaks every year. Moreover, the MLV vaccination of piglets at 2-
3 weeks of age can have beneficial effects on their health and growth performance, including 
reduction of morbidity and mortality rate due to PRRSV infection, as well as improvement 
of average daily gain and feed conversion ratio (Papatsiros, 2011). 
Inactivated vaccines are considered safer than MLV vaccines, as the vaccine virus cannot 
transmit to other pigs and cannot revert to virulence. However, their efficacy has been 
seriously questioned. Field studies reported that the inactivated vaccines did not induce 
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reproductive failure in vaccinated sows and improved efficiently the reproductive 
parameters at a farm level (Plana-Duran et al., 1997; Papatsiros et al., 2006). However, their 
capacity to induce a protective immunity against challenge with wild-type virus has been 
questioned, as these vaccines induce poor immune responses in naïve pigs and provide 
weak memory responses with sequential challenge without any obvious active immune 
responses in the vaccinated pigs (Kim et al., 2011). On the one hand, commercially available 
inactivated vaccines do not induce VN antibodies and do not sufficiently protect against 
viremia or prevent from the clinical signs associated with PRRSV infection, i.e., post-
challenge viremia and transplacental infection of the piglet (Nilubol et al. 2004; Scortti et al., 
2007; Zuckermannet al., 2007). On the other hand, experimental inactivated PRRSV vaccines 
can induce VN antibodies and reduce the duration of viremia (Misinzo et al., 2006, Vanhee 
et al., 2009). However, without VN antibodies induction, a commercial inactivated vaccine 
reported to induce significant improvement of sow reproductive performance and litter 
characteristics (Papatsiros et al., 2006). In addition, some types of adjuvants were used as 
effective vaccine adjuvants to enhance the humoral and cellular responses of piglets against 
PRRSV (Linghua et al., 2007). Hence, the effectiveness of vaccination programme based on 
inactivated vaccine depends on the vaccine (virus strain and used cells to prepare the 
vaccine) and vaccination strategy (Misinzo et al., 2006). 
Based on the Greek experience, the vaccination of gilts and sows with inactivated vaccines can 
have beneficial effects on their health and performance, as well as on their litters. The long 
term use of a commercial inactivated vaccine for a period of 1.5 years in breeding stock of a 
closed single commercial farm with persistent PRRSV infection and high seroprevalence, 
proved to reduce the negative effects of the virus on the breeding herd (Papatsiros et al., 2006). 
The vaccination scheme included a primary vaccination of all gilts/sows of the herd by 
administering two doses 3–4 weeks apart, except those being 1 week prior to 2 weeks post-
service. The skipped females were subjected to primary vaccination, but starting 3 weeks later. 
All previously vaccinated animals received a booster vaccination between 55 and 60 days of 
next gestation, and thereafter at each gestation for a period of 1.5 years. The gilts were 
vaccinated twice prior to breeding (primary vaccination) and boostered in each pregnancy as 
described previously. Vaccinations resulted in a significant improvement of sow reproductive 
performance and their litters’ characteristics, as are shown in Table 3. This study indicated also 
that under practical conditions, the use of an inactivated vaccine should be administered on a 
regular basis for obtaining the maximum of its effect, as it has been observed that the higher 
the degree of immunization of sows, the better the improvement of their reproductive 
parameters. It is interesting to note that while the number of booster vaccinations improved 
several performance parameters, it did not improve the level of immunity as measured by 
IPMA, suggesting that the levels of IPMA-antibodies may not always reflect protection. 
Moreover, the vaccination led to a significant reduction of culling rate due to reproductive 
failure, resulting in an improvement of longevity, herd age distribution and number of non 
productive days in the breeding stock (Table 4). Finally, the long-term vaccination of boars 
with the same inactivated vaccine was safe and no significant changes in semen characteristics 
after each vaccination were noticed (Papatsiros et al., 2008). The above vaccination schedule is 
proposed to be applied on a regular basis in breeding stock of endemic PRRSV-infected farms, 
in order to achieve a stabilization of the immunity status of all breeding herd and prevent the 
losses due to the yearly outbreaks of PRRS. 
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Period relative the start of vaccination 
1 year prior 
(Non 
vaccinated 
sows) 
1.5 years 
after 
(Vaccinated 
sows) 
 
1 year prior 
(Non 
vaccinated 
sows) 
1.5 years 
after 
(Vaccinated 
sows) 
Reproductive parameters  Number of piglets per litter 
Returns to 
oestrus rate (%) 
8.9 a 6.8 b Totally born 11.4a± 3.1 11.6a ± 3.1 
Abortion rate 
(%) 
2.2%a 1.3%b Live born 10.5b ± 3.1 10.9a ± 3.1 
Farrowing rate 
(%) 
87.7%b 90.3%a Stillborn 0.7a ± 1.4 0.5b ± 1.2 
«Empty» sows 
rate (%) 
0.4%a 0.5%a Mummified 0.2a ± 0.6 0.1b ± 0.5 
Premature 
farrowing rate 
(%) 
22.8%a 1.4%b Light weight 1.0a ± 1.6 0.1b ± 0.6 
Farrowing rate 
(%) 
87.7%b 90.3%a Weak 1.5a ± 2.0 0.6b ± 1.5 
Culling rate (%) 24.5%a 21.9%b Splay-legs 0.7a ± 1.0 0.1b ± 0.4 
Gestation length 
(days) 
114.3b ± 2.3 115.2a ± 1.4 Alive first 
24h 
10.1b ± 3.0 10.5a± 3.0 
Lactation length 
(days) 
25.0a ± 3.3 21.6b ± 2.8 Weaned 8.9b ± 1.5 9.3a ± 1.4 
Weaning-to-
service (days) 
6.7a ± 6.3 5.6b ± 3.7  
a.b. Percentages and Means (± SD) in a row with different superscripts differ (P≥0,05). 
Table 3. Reproductive and litter characteristics prior (non vaccinated sows) and after 
(vaccinated sows) the start of vaccination with inactivated vaccine: Source: Papatsiros 2006. 
 Period relative the start of vaccination 
Causes of culling (%)
1 year prior 
(Non vaccinated sows) 
1.5 years after 
(Vaccinated sows) 
Reproductive failure 40.5%a 26.6%b 
Deaths 13.7%a 10.4%a 
Old age 14.8%a 33.9%b 
Locomotor problems 12.5%a 12.7%a 
Other 18.5%a 16.3%a 
a, b Percentages in a row with different superscripts differ (P≤0.05). 
Table 4. Causes of culling in female breeding stock prior (non vaccinated animals) and after 
(vaccinated animals) the start of vaccination with inactivated vaccine. Source: Papatsiros 2006. 
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2.3.2 Gilt development & isolation / acclimatization  
The first step in breaking virus circulation in the breeding herd is to use replacement 
animals that have been exposed to PRRSV and developed immunity prior to their 
introduction into the herd (Dee, 2003). Gilt introduction in breeding population is the key 
for PRRS control, consisting of 3 periods: the isolation period, the acclimatization period, 
and the recovery period (Pesente et al., 2006; Vashisht et al., 2008). The length of each period 
may range from 30 to 60 days, depending on the age of the replacement animal, the PRRS 
history of intra and inter farms, and the type and size of farm. The isolation period consists 
of serological tests (day 1 to 2) in order to determine the PRRSV infection status of the 
incoming animals. The PRRSV vaccination of the incoming breeding stock should be done 
shortly after arrival. The acclimatization period starts 30 days after the introduction of 
replacement gilts, aiming to expose the ‘’new’’ gilts to the specific PRRSV strain of the farm. 
Finally, a period of recovery (at least 30 days) is implemented to reduce the risk of 
introducing actively infected gilts into the breeding herd. By the end of acclimatization 
period, the replacement gilts could be vaccinated against other diseases, such as Aujeszky’s 
disease. Moreover, the acclimatization should be also applied in farms with grandparent 
nucleus of sows for producing its own gilts, which are separately housed (McCaw, 1995).  
Several acclimatization programmes were described, including methods such as: a) 
feedback with tissues from weak-born piglets and stillbirths in the face of outbreaks, b) use 
of MLV and inactivated vaccines, c) contact exposure between gilts and weaning pigs that 
are used as donor sources of virus and d) inoculation of negative replacement animals with 
serum collected from viremic pigs from the same farm (Dee, 2003; Vashisht et al., 2008). The 
use of serum containing viable field virus has recently increased due to the increased genetic 
heterogeneity among PRRSV strains and the perception that commercial vaccines do not 
induce enough protective cross-protection against newly identified PRRSV strains. This 
method has inherent risks and requires thoughtful application and high quality control 
standards (Zimmerman et al., 2006). Consistent acclimatization of incoming breeding stock 
to PRRSV results in: a) the stabilization of clinical signs, b) the production of PRRSV 
negative piglets at weaning, c) the prevention of PRRSV outbreaks associated with endemic 
PRRSV strains, d) the development of specific immunity to the homologous herd strains, 
and e) the improvement of production parameters (Pesente et al., 2006; Vashisht et al., 2008). 
It is generally accepted that early exposure (2–4 months of age) can result in the protection 
of the exposed animals and the introduction of the replacement animals at a time when 
shedding has stopped. Therefore, it is recommended that gilts can be purchased and 
acclimatized at an early age (Vashisht et al., 2008). 
In a closed-herd system, replacements are produced internally and are introduced into the 
sow herd directly from the grower or finisher stage, regardless their PRRSV infection status. 
Generally, closed herd systems do not eliminate PRRSV infection, because replacement gilts 
usually have previous exposure to PRRSV strains circulating in the herd. For this reason, gilt 
developer facilities are very important for introduction of gilts into an infected farm. Gilt 
developer facilities should be located in the sow site or preferably, in an alternative location 
far from the other unites. Gilts may be introduced at the age of weaning piglets or 2 to 5 
months of age, under AIAO pig flow practices.  
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A field study in a commercial farrow-to-finish farm with 1,100 sows, where the gilts were 
housed with finishing pigs, indicated that even if the breeding stock were vaccinated with a 
PRRSV inactivated vaccine for a period of 24 months, the non-vaccinated gilts show high 
(93,3 – 100%) seroprevalence (Figure 1). This was an indication of high virus circulation in 
fattening buildings, but also was important evidence that some infected gilts re-introduced 
PRRSV into the breeding stock (Papatsiros, 2006). 
 
Fig. 1. 
Finally, the strategy of ‘’herd closure’’ could also be applied in order to eliminate the virus 
circulation by the reduction of viral shedding and elimination of carrier pigs. The basis of 
herd closure is the cessation of replacement gilt introduction for an extended period (4 to 8 
months), depending on the herd health status and pig flow. During the period of herd 
closure, the introduction of replacement gilts and boars is discontinued, and only the 
introduction of semen for artificial insemination is allowed. In addition, the vaccination of 
the breeding herd could be applied at this period. However, herd closure can result in the 
production of an improper parity distribution and the development of a PRRSV-negative 
breeding population over time. These effects can be minimized through the use of off-site 
breeding projects for replacement gilts (Cho & Dee, 2006; Zimmerman et al., 2006). 
2.3.3 Other management practices 
McCaw (1995) proposed the McREBEL (Management Changes to Reduce Exposure to 
Bacteria to Eliminate Losses) system for PRRS control. The aim of McREBEL is to maximize 
the number of piglets remaining with their birth mother and, secondly, to maximize the 
number of piglets remaining with the colostrum mother. According to the author, the 
McREBEL system reduces considerably the economic losses, without eliminate successfully 
the virus circulation in the farm. This system is recommended to be applied in farms with 
separate premises for the different ages both at farrowing and in newly weaned piglets, 
using the AIAO system as following:  
specific antibody 
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i. Limitation or interruption of the cross-fostering of newborn piglets for resizing or 
saving sick pigs, fall-behinds, and runts. The cross-fostering of piglets should be 
performed only within the first 24 hours of age. 
ii. Piglets should be moved within farrowing rooms at birth and not between different 
rooms to ‘’nurse sows’’ (especially poor-doing or possibly diseased piglets to younger 
age groups attempting to save them). In addition, sows or piglets should not be moved 
between rooms. 
iii. Interruption of using ‘’nurse sows’’ for weak-born PRRSV-infected pigs, fall-behinds, 
and runts. 
iv. Minimization of piglets’ handling, especially routine antibiotic treatments. The effect of 
each handling or treatment procedure should be evaluated on clinical disease levels. 
v. Immediate euthanization of all very sick and debilitated piglets those are non-
responsive to therapy. 
vi. Sick or lightweight piglets should not be retained with or mixed with younger piglets. 
Euthanization of small piglets with poor body condition at weaning. 
vii. Suckling and weaning piglets should only be moved AIAO, by room. 2-3 days should 
be allowed between batches for cleaning and disinfection and drying.  
viii. Weaning piglets should be loaded at a time with earlier weaning of a few of the oldest 
and biggest litters.  
Co-infections of PRRS by several other respiratory pathogens have the ability to increase 
both the severity and duration of PRRS associated disease. For this reason, a porcine herd 
health management for the prevention and control of PRRSV infection should also include 
measures for the control of bacterial co-infections (e.g. Haemophilus parasuis, Streptococcus 
suis, Actinobacillus pleuropneumoniae, Pastereula multocida) and viral diseases such as swine 
influenza, Aujeszky’s disease and PCV2 associated diseases. Appropriate medication and 
vaccination protocols need to be applied for the individual infections. Water soluble 
antimicrobials or feed medications can be selected based on the sensitivity pattern of the 
secondary bacteria. Oxytetracycline, chorotetracycline, trimethoprim/sulpha, or synthetic 
penicillins are the medicines of choice, but tiamulin, tylosin or lincomycin may be also used. 
If Actinobacillus pleuropneumonia is active, ceftiofur or florfenicol could be medicines of 
choice for individual treatments. Feed medications (e.g. 500 to 800g of tetracycline or 400g of 
trimethoprim/sulpha per tonne in-feed) must be provided at the earliest possible post 
infection time in order to maximise efficacy. Anti-fever drugs may be used to decrease the 
negative effects of fever, such as it depresses appetite, abortion in sows, and decreases milk 
production. Finally, vaccination protocols should be applied, including vaccines against 
viral pathogens such as PCV2, swine influenza virus and Aujeszky’s disease virus, as well 
as bacterial pathogens such as Mycoplasma hyopneumoniae, Actinobacillus pleuropneumoniae 
and Haemophilus parasuis. The most important vaccinations of weaning pigs in farms 
suffering from PRDC are considered those against Mycoplasma hyopneumoniae and PCV2 
(Alexopoulos et al., 2004). 
3. Monitoring serology  
The preliminary diagnosis of PRRSV infection is most often based on a review of herd 
history and clinical signs. Gross post mortem findings can help to confirm the suspicions 
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and finally serological, histological, immunohistochemistry and PCR examinations can 
confirm the diagnosis. Because of the PRRSV genetic diversity, it is preferable to isolate and 
characterize the farm specific PRRSV strains, using genetic typing such as restriction 
fragment length polymorphism (RFLP) and gene sequencing. This allows also determining 
any new PRRSV strain (Zimmerman et al., 2006). 
Before starting a vaccination programme, it is essential to investigate when the PRRSV 
infection took place. Routine serological monitoring tests for PRRSV serum antibodies are 
very useful diagnostic tools for the determination of PRRSV herd exposure status. 
Therefore, the vaccination programme can be applied prior to the usual infection time in 
order to provide efficient protection in vaccinated animals. The serological diagnostics of 
PRRS include enzyme-linked immunosorbent assay (ELISA), blocking ELISA, serum virus 
neutralization (SVN), indirect fluorescent antibody (IFA) and immunoperoxidase 
monolayer assay (IPMA). The IFA has high specificity (99.5%), but unknown sensitivity 
for individual animals, while the IPMA is also considered to be a highly specific and 
sensitive test (Wensvoort et al., 1991). The ELISA is also reported to be sensitive and 
specific (O’Connor et al., 2002). The specificity of a commercial PRRS ELISA (HerdChek® 
PRRS ELISA, IDEXX Laboratories Inc., Westbrook, Maine), has been estimated to be 
between 99.3 and 99.5 % (O’Connor et al., 2002). The ELISA is well-suited for monitoring 
since it is sensitive, specific, standardized, simple to perform, relatively inexpensive, easy 
to implement, able to detect both American and European strains, and potential for rapid 
analysis of numerous serum samples. Antibodies can be detected as early as 9 DPI (days 
post infection), peak at 30–50 DPI and then decline to negative levels 4–12 months after 
infection. ELISA results are interpreted as positive when a sample-to – positive (S/P) ratio 
≥ 0.4 (indicates presence of antibody to PRRSV) or negative (S/P <0.4). The demonstration 
of seroconversion (negative to positive), using acute and convalescent serum samples, is 
the most definitive method to diagnose PRRSV infection serologically. Increasing titers of 
PRRSV specific antibody demonstrated by rising ELISA S/P ratios in a group of infected 
animals can also indicate PRRSV infection. Finally, sequencing of PRRSV isolates followed 
by phylogenetic analysis is a powerful tool to monitor the spread of virus intra and inter 
farms and allows a fuller understanding of the success or failure of the control 
programme (Pesente et al., 2006). The ELISA in all of its current forms is the best practical 
diagnostic method to detect exposure events and confirm vaccinations, but it is not a 
reliable indicator of protection against PRRSV. 
The number of serum blood samples needed to identify an infected herd depends on the 
seroprevalence. Shortly after an acute outbreak, the prevalence of seropositive pigs in 
infected herds is high. For this reason, it is possible to identify infected herds by testing only 
a small number of samples. In case of a herd with unknown serostatus, more samples from 
breeding herd than from a finishing herd should be tested, because seroprevalence in 
breeding herd is usually lower compared to seroprevalence in finishing herd. A porcine 
herd health management programme for the control of PRRS should include a herd 
serological monitoring, once or twice per year. The herd serostatus is predicted by testing a 
representative number of animals. The number and ages of animals to be tested is 
determined by the assumed seroprevalence in each age group. Seroprevalence to PRRSV in 
the breeding herd can vary widely depending on how long the herd has been infected. 
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Herds with a recent history of reproductive failure have often been infected less than 1 
year and tend to have a high seroprevalence (approximately 50%) in breeding animals. To 
detect seropositive animals with 95% confidence (assume 50% seroprevalence in the 
breeding herd) at least 10-20 blood samples from breeding stock is recommended. In 
endemic PRRSV-infected herds, which have probably been infected more than 1 year, the 
seroprevalence is usually low in the breeding herd (20% or less) and high in the finishing 
pigs (50% or greater) (Stevenson et al., 1993). For example, in a breeding herd of 100 
animals, to detect seropositive animals with 95% confidence (assume 10% seroprevalence 
in breeders and 50% seroprevalence in finishing pigs) at least 25 blood samples from 
breeding stock and 7 from finishing pigs are recommended. However, herd serology only 
demonstrates previous exposure to the virus and does not provide a definitive diagnosis 
of PRRSV as a cause for the clinical problems on the farm. It is generally recommended 
that young pigs (10-15 blood samples from pigs at 3, 5, 7, 9 weeks and 16 of age), rather 
than breeding stock, should be tested to determine PRRSV circulation and infection status 
in a herd. In single-site, farrow-to-finish herds, the seroprevalence of PRRSV infection is 
usually considered to be highest in the grow-finish unit. Moreover, in herds without 
clinical signs of PRRS, testing 12 blood samples in both PCR and ELISA, (6 samples in 
pigs 9 weeks of age and 6 samples in pigs 16 weeks of age), is reported as a cost-efficient 
first evaluation of the PRRSV infection-status (Duinhof et al., 2011). In order to detect an 
increasing seroprevalence over time is preferable to perform serology in nursery pigs, 
including ear tagging and bleeding 10-20 pigs at 3-4 weeks of age and bleeding the same 
pigs at 7-8 weeks of age (Van Alstine et al., 1993). A greater percentage of seropositive 
pigs at the second bleeding would indicate that the virus is actively spreading among pigs 
on the farm. This may be confounded by passively acquired maternal antibody that 
usually lasts for 6-8 weeks, but can last up to 16 weeks of age.  
4. Conclusion 
PRRS remains to have a great negative economic impact on the the global swine industry. 
The control of PRRS economic losses in commercial swine farms is a challenge for farmers 
and swine veterinarians. Many factors including management practices and pig flow, the 
level of risk associated with local pig density, and the inherent characteristics of the specific 
PRRSV strains on farm level contribute to a successful a porcine herd health management 
programme development. The goal of a porcine herd health management to control PRRSV 
infection is based mainly on: a) minimizing the virus transmission and circulation in the 
farm, b) maximizing the herd immunity against PRRSV and c) limiting the losses due to 
secondary co-infections. A good knowledge of PRRS disease at the farm level, the 
establishment of strict biosecurity measures, acclimatization of replacement gilts by 
exposure to the specific PRRSV circulating strains in farm as well as the application of 
appropriate vaccination programme are commonly considered the most sound strategies to 
control PRRS. Furthermore, a completed herd history, assessment of clinical signs and 
proper diagnostic tests are very important tools for a swine veterinarian practitioner to 
control successfully PRRSV infections. Among the diagnostic tests, ELISA is the best 
practical diagnostic method to detect exposure events and confirm vaccinations, but it is not 
a reliable indicator of protection against PRRSV. 
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Finally, the establishment of a porcine herd health management programme to control PRRS 
is an excellent investment for swine farmers in order to improve the herd health status and 
reduce the cost of pork meat production. 
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